Hyperfine, Inc. $HYPR Shares Acquired by Catalio Capital Management LP

Catalio Capital Management LP lifted its position in shares of Hyperfine, Inc. (NASDAQ:HYPR) by 92.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,320,041 shares of the company’s stock after acquiring an additional 635,500 shares during the period. Catalio Capital Management LP’s holdings in Hyperfine were worth $1,293,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Hyperfine by 5.7% during the 3rd quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock valued at $5,092,000 after acquiring an additional 190,136 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Hyperfine by 21.4% during the 4th quarter. Geode Capital Management LLC now owns 815,986 shares of the company’s stock valued at $799,000 after acquiring an additional 143,975 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of Hyperfine by 674.4% during the 4th quarter. Renaissance Technologies LLC now owns 364,743 shares of the company’s stock valued at $357,000 after acquiring an additional 317,645 shares in the last quarter. State Street Corp raised its position in shares of Hyperfine by 6.1% during the 4th quarter. State Street Corp now owns 265,195 shares of the company’s stock valued at $260,000 after acquiring an additional 15,200 shares in the last quarter. Finally, Walleye Capital LLC acquired a new stake in shares of Hyperfine during the 4th quarter valued at approximately $212,000. 15.03% of the stock is owned by institutional investors and hedge funds.

Hyperfine Price Performance

Shares of NASDAQ HYPR opened at $1.39 on Thursday. Hyperfine, Inc. has a 1-year low of $0.66 and a 1-year high of $2.22. The firm has a market capitalization of $137.99 million, a PE ratio of -3.39 and a beta of 1.38. The business’s fifty day moving average price is $1.44 and its two-hundred day moving average price is $1.22. The company has a debt-to-equity ratio of 0.38, a current ratio of 5.52 and a quick ratio of 4.90.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 98.83% and a negative net margin of 226.88%.The company had revenue of $3.90 million during the quarter, compared to analysts’ expectations of $3.54 million. On average, research analysts expect that Hyperfine, Inc. will post -0.34 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Brett Hale sold 24,188 shares of the stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the transaction, the chief financial officer owned 275,812 shares in the company, valued at $333,732.52. This trade represents a 8.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Thomas Teisseyre sold 24,188 shares of the stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the transaction, the chief operating officer owned 354,648 shares of the company’s stock, valued at $429,124.08. This trade represents a 6.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 60,470 shares of company stock valued at $78,490 in the last quarter. 26.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. BTIG Research assumed coverage on Hyperfine in a research report on Wednesday, April 29th. They issued a “buy” rating and a $2.00 target price on the stock. Lake Street Capital increased their target price on Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a research report on Thursday, March 19th. B. Riley Financial reaffirmed a “buy” rating on shares of Hyperfine in a research report on Wednesday, May 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Tuesday, April 21st. Finally, Zacks Research raised Hyperfine to a “hold” rating in a research report on Thursday, March 19th. Three equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $1.78.

Hyperfine Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.